Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-02-06 Sale | 2025-02-06 8:06 pm | Revance Therapeutics Inc. | RVNC | Gangolli Julian S Director | 15,000 | $0 | $0 | 0 (Direct) | View |
| 2025-02-06 Sale | 2025-02-06 3:59 pm | Revance Therapeutics Inc. | RVNC | Foley Mark J President & CEO | 112,619 | $0 | $0 | 0 (Indirect Direct) | View |
| 2025-02-06 Sale | 2025-02-06 3:59 pm | Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO | 124,438 | $0 | $0 | 0 (Direct) | View |
| 2025-02-06 Sale | 2025-02-06 3:58 pm | Revance Therapeutics Inc. | RVNC | Moxie Dwight CLO & GC | 114,104 | $0 | $0 | 0 (Direct) | View |
| 2025-02-06 Sale | 2025-02-06 3:58 pm | Revance Therapeutics Inc. | RVNC | Hollander David CMO & Global Therapeutics Lead | 95,212 | $0 | $0 | 0 (Direct) | View |
| 2025-02-06 Sale | 2025-02-06 3:57 pm | Revance Therapeutics Inc. | RVNC | Jordan Erica Chief Commercial Officer | 107,942 | $0 | $0 | 0 (Direct) | View |
| 2025-02-06 Sale | 2025-02-06 3:56 pm | Revance Therapeutics Inc. | RVNC | Ware Olivia C Director | 15,000 | $0 | $0 | 0 (Direct) | View |
| 2025-02-06 Sale | 2025-02-06 3:56 pm | Revance Therapeutics Inc. | RVNC | Kolaja Carey OConnor Director | 15,000 | $0 | $0 | 0 (Direct) | View |
| 2025-02-06 Sale | 2025-02-06 3:49 pm | Revance Therapeutics Inc. | RVNC | Coric Vlad Director | 15,000 | $0 | $0 | 0 (Direct) | View |
| 2025-02-06 Sale | 2025-02-06 3:49 pm | Revance Therapeutics Inc. | RVNC | Beraud Jill Director | 15,000 | $0 | $0 | 0 (Direct) | View |
| 2025-02-06 Sale | 2025-02-06 3:48 pm | Revance Therapeutics Inc. | RVNC | Nolet Chris Director | 15,000 | $0 | $0 | 0 (Direct) | View |
| 2025-02-06 Sale | 2025-02-06 3:45 pm | Revance Therapeutics Inc. | RVNC | Russell Angus C. Director | 15,000 | $0 | $0 | 0 (Direct) | View |
| 2024-11-18 Sale | 2024-11-19 4:31 pm | Revance Therapeutics Inc. | RVNC | Hollander David CMO & Global Therapeutics Lead | 3,908 | $4.17 | $16,296 | 104,945 (Direct) | View |
| 2024-04-16 Sale | 2024-04-17 4:34 pm | Revance Therapeutics Inc. | RVNC | Jordan Erica Chief Commercial Officer | 2,392 | $3.8028 | $9,096 | 114,864 (Direct) | View |
| 2024-03-18 Sale | 2024-03-19 6:45 pm | Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President | 9,211 | $5.0425 | $46,446 | 167,550 (Direct) | View |
| 2024-03-18 Sale | 2024-03-19 6:44 pm | Revance Therapeutics Inc. | RVNC | Moxie Dwight CLO & GC | 8,125 | $5.0426 | $40,971 | 137,815 (Direct) | View |
| 2024-03-18 Sale | 2024-03-19 6:44 pm | Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO | 9,361 | $5.0426 | $47,204 | 192,666 (Direct) | View |
| 2024-03-06 Purchase | 2024-03-08 4:33 pm | Revance Therapeutics Inc. | RVNC | Foley Mark J CEO | 30,000 | $6.98 | $209,400 | 1,126,381 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-04 Equity Swap | 2025-02-06 8:06 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Gangolli Julian S Director | 30,106 | $3.65 | 0 (Direct) | View |
| 2025-02-06 Option Award | 2025-02-06 3:59 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Foley Mark J President & CEO | 84,686 | $0 | 0 (Direct) | View |
| 2025-02-04 Equity Swap | 2025-02-06 3:59 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Foley Mark J President & CEO | 1,107,848 | $3.65 | 0 (Direct) | View |
| 2025-02-06 Option Award | 2025-02-06 3:59 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO | 20,883 | $0 | 0 (Direct) | View |
| 2025-02-04 Equity Swap | 2025-02-06 3:59 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO | 97,999 | $3.65 | 0 (Direct) | View |
| 2025-02-06 Option Award | 2025-02-06 3:58 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Moxie Dwight CLO & GC | 18,125 | $0 | 0 (Direct) | View |
| 2025-02-04 Equity Swap | 2025-02-06 3:58 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Moxie Dwight CLO & GC | 47,815 | $3.65 | 0 (Direct) | View |
| 2025-02-04 Equity Swap | 2025-02-06 3:58 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Hollander David CMO & Global Therapeutics Lead | 9,733 | $3.65 | 0 (Direct) | View |
| 2025-02-04 Equity Swap | 2025-02-06 3:57 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Jordan Erica Chief Commercial Officer | 6,922 | $3.65 | 0 (Direct) | View |
| 2025-02-04 Equity Swap | 2025-02-06 3:56 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Ware Olivia C Director | 16,675 | $3.65 | 0 (Direct) | View |
| 2025-02-04 Equity Swap | 2025-02-06 3:56 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Kolaja Carey OConnor Director | 16,561 | $3.65 | 0 (Direct) | View |
| 2025-02-04 Equity Swap | 2025-02-06 3:49 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Coric Vlad Director | 5,784 | $3.65 | 0 (Direct) | View |
| 2025-02-04 Equity Swap | 2025-02-06 3:49 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Beraud Jill Director | 28,606 | $3.65 | 0 (Direct) | View |
| 2025-02-04 Equity Swap | 2025-02-06 3:48 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Nolet Chris Director | 28,606 | $3.65 | 0 (Direct) | View |
| 2025-02-04 Equity Swap | 2025-02-06 3:45 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Russell Angus C. Director | 36,506 | $3.65 | 0 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-05 7:53 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Foley Mark J CEO | 27,933 | $0 | 1,135,781 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-05 7:53 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO | 6,888 | $0 | 201,554 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-05 7:53 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Moxie Dwight CLO & GC | 5,979 | $0 | 143,794 (Direct) | View |
| 2024-12-31 Option Award | 2025-01-03 4:34 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO | 1,000 | $2.1845 | 194,666 (Direct) | View |
| 2024-12-31 Option Award | 2025-01-03 4:33 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Foley Mark J CEO | 1,000 | $2.1845 | 1,107,848 (Direct) | View |
| 2024-06-30 Option Award | 2024-07-02 5:47 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Foley Mark J CEO | 1,000 | $2.1845 | 1,106,848 (Direct) | View |
| 2024-06-30 Option Award | 2024-07-02 5:47 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO | 1,000 | $2.1845 | 193,666 (Direct) | View |
| 2024-05-01 Option Award | 2024-05-03 08:47 am | N/A 2034-04-30 | Revance Therapeutics Inc. | RVNC | Ware Olivia C Director | 38,458 | $0 | 55,133 (Direct) | View |
| 2024-05-01 Option Award | 2024-05-03 08:47 am | N/A 2034-04-30 | Revance Therapeutics Inc. | RVNC | Russell Angus C. Director | 38,458 | $0 | 74,964 (Direct) | View |
| 2024-05-01 Option Award | 2024-05-03 08:46 am | N/A 2034-04-30 | Revance Therapeutics Inc. | RVNC | Nolet Chris Director | 38,458 | $0 | 67,064 (Direct) | View |
| 2024-05-01 Option Award | 2024-05-03 08:45 am | N/A 2034-04-30 | Revance Therapeutics Inc. | RVNC | Kolaja Carey OConnor Director | 38,458 | $0 | 55,019 (Direct) | View |
| 2024-05-01 Option Award | 2024-05-03 08:44 am | N/A 2034-04-30 | Revance Therapeutics Inc. | RVNC | Gangolli Julian S Director | 38,458 | $0 | 68,564 (Direct) | View |
| 2024-05-01 Option Award | 2024-05-03 08:43 am | N/A 2034-04-30 | Revance Therapeutics Inc. | RVNC | Coric Vlad Director | 38,458 | $0 | 44,242 (Direct) | View |
| 2024-05-01 Option Award | 2024-05-03 08:42 am | N/A 2034-04-30 | Revance Therapeutics Inc. | RVNC | Beraud Jill Director | 38,458 | $0 | 67,064 (Direct) | View |
| 2024-03-15 Tax Withholding | 2024-03-19 6:45 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President | 2,967 | $5.305 | 167,550 (Direct) | View |
| 2024-03-15 Tax Withholding | 2024-03-19 6:44 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Moxie Dwight CLO & GC | 3,269 | $5.305 | 137,815 (Direct) | View |
| 2024-03-15 Tax Withholding | 2024-03-19 6:44 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO | 3,822 | $5.305 | 192,666 (Direct) | View |
| 2024-03-15 Tax Withholding | 2024-03-19 6:43 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Foley Mark J CEO | 20,533 | $5.305 | 1,105,848 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 5:34 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President | 22,110 | $0 | 179,728 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 5:33 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Moxie Dwight CLO & GC | 15,143 | $0 | 149,209 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 4:44 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO | 17,447 | $0 | 205,849 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 4:33 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Foley Mark J CEO | 70,750 | $0 | 1,096,381 (Direct) | View |
Ownership | 2024-02-29 4:36 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Jordan Erica Chief Commercial Officer | 0 | $0 | 237,256 (Direct) | View |
Ownership | 2024-02-29 4:32 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Hollander David CMO & Global Therapeutics Lead | 0 | $0 | 278,522 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 4:48 pm | 2025-02-15 2028-01-31 | Revance Therapeutics Inc. | RVNC | Moxie Dwight SVP, GC & Secretary | 225,000 | $0 | 269,066 (Direct) | View |